Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal articles
- Journal Article
Flaig, TW; Spiess, PE; Abern, M; An, Y; Bangs, R; Begovic, J; Brown, J; Buyyounouski, MK; Chan, K; Chang, P; Chin, AI; Guru, KA; Herr, HW ...
Published in: J Natl Compr Canc Netw
May 2026
The NCCN Guidelines for Bladder Cancer provide strategies for the diagnosis, treatment, and follow-up of patients with bladder cancer, which is the sixth most common cancer in the United States. Bladder cancer can be divided into 3 categories along a clinical spectrum: (1) non-muscle-invasive bladder cancer; (2) muscle-invasive bladder cancer; and (3) metastatic bladder cancer, with most patients falling into the category of non-muscle-invasive disease. Thus, the selected content featured in this issue specifically covers the clinical presentation and workup of and subsequent management recommendations for non-muscle-invasive bladder cancer.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2026
Volume
24
Issue
5
Start / End Page
186 / 203
Location
United States
Related Subject Headings
- Urinary Bladder Neoplasms
- United States
- Oncology & Carcinogenesis
- Non-Muscle Invasive Bladder Neoplasms
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Flaig, T. W., Spiess, P. E., Abern, M., An, Y., Bangs, R., Begovic, J., … Sliker, B. (2026). Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw, 24(5), 186–203. https://doi.org/10.6004/jnccn.2026.0022
Flaig, Thomas W., Philippe E. Spiess, Michael Abern, Yi An, Rick Bangs, Jovan Begovic, Jason Brown, et al. “Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.” J Natl Compr Canc Netw 24, no. 5 (May 2026): 186–203. https://doi.org/10.6004/jnccn.2026.0022.
Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, et al. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 May;24(5):186–203.
Flaig, Thomas W., et al. “Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.” J Natl Compr Canc Netw, vol. 24, no. 5, May 2026, pp. 186–203. Pubmed, doi:10.6004/jnccn.2026.0022.
Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, Brown J, Buyyounouski MK, Chan K, Chang P, Chin AI, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kundu S, Lele SM, Luckenbaugh A, Maldonado J, Mei L, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Seyedin S, Siefker-Radtke AO, Stewart T, Sundi D, Swami U, Tollefson M, Wright JL, Cassara CJ, Sliker B. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 May;24(5):186–203.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2026
Volume
24
Issue
5
Start / End Page
186 / 203
Location
United States
Related Subject Headings
- Urinary Bladder Neoplasms
- United States
- Oncology & Carcinogenesis
- Non-Muscle Invasive Bladder Neoplasms
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis